J Neurol Neurosurg Psychiatry 83:467-469 doi:10.1136/jnnp-2011-301102
  • PostScript
  • Letter

Contamination with gangliosides in brain-derived rabies vaccine may trigger Guillain–Barré syndrome

  1. Nobuhiro Yuki1,2
  1. 1Department of Microbiology, National University of Singapore, Singapore
  2. 2Department of Medicine, National University of Singapore, Singapore
  1. Correspondence to Professor Nobuhiro Yuki, Department of Microbiology, National University of Singapore, Block MD4A, Level 5, 5 Science Drive 2, Singapore 117597, Singapore; micyuki{at}
  1. Contributors HS: data collection and figure generation. FMH: literature search and data collection. NY: study design. NY: literature search, study design, data interpretation, figure generation and manuscript composition.

  • Received 2 August 2011
  • Revised 21 August 2011
  • Accepted 24 August 2011
  • Published Online First 23 September 2011

Guillain–Barré syndrome (GBS) is an autoimmune-mediated peripheral neuropathy typically occurring after microbial infections such as Campylobacter jejuni enteritis. It can also occur following vaccinations such as the 1976 swine flu vaccine in the USA.1 GBS is divided into demyelinating and axonal subtypes. There is now good evidence that gangliosides or similar components trigger the development of axonal GBS.2 Axonal GBS associated with IgG anti-GM1 or anti-GD1a antibodies after bovine brain ganglioside administration have been recorded in several patients. Sensitisation of rabbits with bovine brain gangliosides or isolated GM1 produced a replica of axonal GBS. Based on these findings, it has been suggested that C jejuni components mimic human gangliosides GM1 and GD1a, and C jejuni infection induces the production of autoantibodies against the gangliosides that are expressed in the peripheral nerves, resulting in the limb weakness seen in GBS. By contrast, the mechanism by which certain vaccines elicit the development of GBS remains unresolved, although there have been studies to suggest that the 1976 swine flu vaccine could elicit anti-GM1 antibodies in mice and that the GM1 epitope was present in the influenza haemagglutinin.3

It is important to understand the pathogenesis of postvaccination GBS to allow safer vaccines to be developed. A number of cases …

Visit the full archive of podcasts for JNNP here >>

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JNNP.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article